What is the data for adding bortezomib to the conditioning regimen for Auto-SCT in multiple myeloma?

There was a phase-2 trial by Roussel et.al in Blood 2010 [Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple...

09 October 2015 5,360 3 View